Search

Jennifer Sue Pitrak Mcdonald

Examiner (ID: 5815, Phone: (571)270-3061 , Office: P/1674 )

Most Active Art Unit
1635
Art Unit(s)
1635, 3792, 1674, 3796, 1609
Total Applications
600
Issued Applications
220
Pending Applications
26
Abandoned Applications
355

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19246411 [patent_doc_number] => 20240197395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => ABLATION SYSTEM WITH AUTOMATED ABLATION ENERGY ELEMENT [patent_app_type] => utility [patent_app_number] => 18/393371 [patent_app_country] => US [patent_app_date] => 2023-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24753 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18393371 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/393371
ABLATION SYSTEM WITH AUTOMATED ABLATION ENERGY ELEMENT Dec 20, 2023 Abandoned
Array ( [id] => 18986646 [patent_doc_number] => 20240058615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => METHODS AND SYSTEMS FOR REDUCING INTERFERENCE IN STIMULATION TREATMENT [patent_app_type] => utility [patent_app_number] => 18/460963 [patent_app_country] => US [patent_app_date] => 2023-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15847 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18460963 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/460963
METHODS AND SYSTEMS FOR REDUCING INTERFERENCE IN STIMULATION TREATMENT Sep 4, 2023 Abandoned
Array ( [id] => 18418814 [patent_doc_number] => 20230173274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => HIGH FREQUENCY ELECTROMAGNETIC STIMULATION FOR MODULATING CELLS, INCLUDING SPONTANEOUSLY ACTIVE AND QUIESCENT CELLS, AND ASSOCIATED SYSTEMS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/889633 [patent_app_country] => US [patent_app_date] => 2022-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14779 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17889633 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/889633
HIGH FREQUENCY ELECTROMAGNETIC STIMULATION FOR MODULATING CELLS, INCLUDING SPONTANEOUSLY ACTIVE AND QUIESCENT CELLS, AND ASSOCIATED SYSTEMS AND METHODS Aug 16, 2022 Abandoned
Array ( [id] => 17752550 [patent_doc_number] => 20220230755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => Systems and Methods for Cognitive Diagnostics for Neurological Disorders: Parkinson's Disease and Comorbid Depression [patent_app_type] => utility [patent_app_number] => 17/716464 [patent_app_country] => US [patent_app_date] => 2022-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7829 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716464 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/716464
Systems and Methods for Cognitive Diagnostics for Neurological Disorders: Parkinson's Disease and Comorbid Depression Apr 7, 2022 Abandoned
Array ( [id] => 18182320 [patent_doc_number] => 20230043049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => MOBILE CONFIGURABLE LIGHT THERAPY DEVICE [patent_app_type] => utility [patent_app_number] => 17/397487 [patent_app_country] => US [patent_app_date] => 2021-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5669 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17397487 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/397487
MOBILE CONFIGURABLE LIGHT THERAPY DEVICE Aug 8, 2021 Abandoned
Array ( [id] => 18034907 [patent_doc_number] => 20220379122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => Manufacturing Method for an Implantable Medical Device [patent_app_type] => utility [patent_app_number] => 17/775448 [patent_app_country] => US [patent_app_date] => 2020-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3790 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17775448 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/775448
Manufacturing Method for an Implantable Medical Device Dec 8, 2020 Abandoned
Array ( [id] => 17686108 [patent_doc_number] => 20220193400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => NEURAL INTERFACE [patent_app_type] => utility [patent_app_number] => 17/594622 [patent_app_country] => US [patent_app_date] => 2020-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6502 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594622 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/594622
NEURAL INTERFACE Apr 23, 2020 Abandoned
Array ( [id] => 17655687 [patent_doc_number] => 20220176152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => METHOD AND SYSTEM FOR IMPROVING LIGHT INTAKE, LIGHT EXPOSURE, AND LIFESTYLE MANAGEMENT OF A USER [patent_app_type] => utility [patent_app_number] => 17/598931 [patent_app_country] => US [patent_app_date] => 2020-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598931 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/598931
METHOD AND SYSTEM FOR IMPROVING LIGHT INTAKE, LIGHT EXPOSURE, AND LIFESTYLE MANAGEMENT OF A USER Mar 31, 2020 Abandoned
Array ( [id] => 16267572 [patent_doc_number] => 20200269059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => APPARATUS, SYSTEMS, AND METHODS TO IMPROVE ATRIAL FIBRILLATION OUTCOMES INVOLVING THE LEFT ATRIAL APPENDAGE [patent_app_type] => utility [patent_app_number] => 16/796895 [patent_app_country] => US [patent_app_date] => 2020-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12951 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796895 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/796895
APPARATUS, SYSTEMS, AND METHODS TO IMPROVE ATRIAL FIBRILLATION OUTCOMES INVOLVING THE LEFT ATRIAL APPENDAGE Feb 19, 2020 Pending
Array ( [id] => 15927099 [patent_doc_number] => 20200155183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => ARTICULATING SURGICAL TOOLS AND TOOL SHEATHS, AND METHODS OF DEPLOYING THE SAME [patent_app_type] => utility [patent_app_number] => 16/454606 [patent_app_country] => US [patent_app_date] => 2019-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15421 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454606 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/454606
ARTICULATING SURGICAL TOOLS AND TOOL SHEATHS, AND METHODS OF DEPLOYING THE SAME Jun 26, 2019 Abandoned
Array ( [id] => 15356001 [patent_doc_number] => 10526603 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-01-07 [patent_title] => Double-stranded ribonucleic acid capable of suppressing expression of complement C5 [patent_app_type] => utility [patent_app_number] => 16/354916 [patent_app_country] => US [patent_app_date] => 2019-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14006 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16354916 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/354916
Double-stranded ribonucleic acid capable of suppressing expression of complement C5 Mar 14, 2019 Issued
Array ( [id] => 14808431 [patent_doc_number] => 20190270825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-05 [patent_title] => METHODS AND COMPOSITIONS FOR REDUCING CARDIAC DAMAGE AND OTHER CONDITIONS [patent_app_type] => utility [patent_app_number] => 16/255521 [patent_app_country] => US [patent_app_date] => 2019-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16614 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16255521 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/255521
Methods and compositions for reducing cardiac damage and other conditions Jan 22, 2019 Issued
Array ( [id] => 14043969 [patent_doc_number] => 20190078091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-14 [patent_title] => ANTISENS OLIGONUCLEOTIDES FOR THE TREATMENT OF LEBER CONGENITAL AMAUROSIS [patent_app_type] => utility [patent_app_number] => 16/197865 [patent_app_country] => US [patent_app_date] => 2018-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12863 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16197865 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/197865
Antisense oligonucleotides for the treatment of Leber congenital amaurosis Nov 20, 2018 Issued
Array ( [id] => 14930651 [patent_doc_number] => 20190300963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => MIRNA EXPRESSION SIGNATURE IN THE CLASSIFICATION OF THYROID TUMORS [patent_app_type] => utility [patent_app_number] => 16/192221 [patent_app_country] => US [patent_app_date] => 2018-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34039 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 218 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16192221 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/192221
MIRNA EXPRESSION SIGNATURE IN THE CLASSIFICATION OF THYROID TUMORS Nov 14, 2018 Abandoned
Array ( [id] => 15832465 [patent_doc_number] => 20200131514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => METHOD FOR ISOLATING CROSS-REACTIVE APTAMER AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/174764 [patent_app_country] => US [patent_app_date] => 2018-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19885 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16174764 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/174764
Method for isolating cross-reactive aptamer and use thereof Oct 29, 2018 Issued
Array ( [id] => 15816975 [patent_doc_number] => 10633654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-28 [patent_title] => Modified RNAi polynucleotides and uses thereof [patent_app_type] => utility [patent_app_number] => 16/153424 [patent_app_country] => US [patent_app_date] => 2018-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 37 [patent_no_of_words] => 29448 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16153424 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/153424
Modified RNAi polynucleotides and uses thereof Oct 4, 2018 Issued
Array ( [id] => 13790895 [patent_doc_number] => 20190008986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-10 [patent_title] => OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 16/139091 [patent_app_country] => US [patent_app_date] => 2018-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 225611 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16139091 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/139091
Oligonucleotide compositions and methods thereof Sep 22, 2018 Issued
Array ( [id] => 13622855 [patent_doc_number] => 20180362979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-20 [patent_title] => THERAPEUTIC AND DIAGNOSTIC MOLECULES [patent_app_type] => utility [patent_app_number] => 16/056393 [patent_app_country] => US [patent_app_date] => 2018-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10751 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16056393 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/056393
THERAPEUTIC AND DIAGNOSTIC MOLECULES Aug 5, 2018 Abandoned
Array ( [id] => 15634889 [patent_doc_number] => 10590423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-17 [patent_title] => Treatment of age-related macular degeneration using RNA complexes that target MyD88 or TLR3 [patent_app_type] => utility [patent_app_number] => 16/042833 [patent_app_country] => US [patent_app_date] => 2018-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13328 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16042833 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/042833
Treatment of age-related macular degeneration using RNA complexes that target MyD88 or TLR3 Jul 22, 2018 Issued
Array ( [id] => 15912981 [patent_doc_number] => 10653712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-19 [patent_title] => High purity RNA compositions and methods for preparation thereof [patent_app_type] => utility [patent_app_number] => 16/001786 [patent_app_country] => US [patent_app_date] => 2018-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 52 [patent_no_of_words] => 38211 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16001786 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/001786
High purity RNA compositions and methods for preparation thereof Jun 5, 2018 Issued
Menu